| scholarly article | Q13442814 |
| P356 | DOI | 10.1006/BBRC.2001.4256 |
| P698 | PubMed publication ID | 11162652 |
| P2093 | author name string | Nagai R | |
| Zhu W | |||
| Sano H | |||
| Horiuchi S | |||
| Miyazaki A | |||
| Fukuhara K | |||
| P433 | issue | 4 | |
| P304 | page(s) | 1183-1188 | |
| P577 | publication date | 2001-02-01 | |
| P1433 | published in | Biochemical and Biophysical Research Communications | Q864228 |
| P1476 | title | The role of galectin-3 in endocytosis of advanced glycation end products and modified low density lipoproteins | |
| P478 | volume | 280 |
| Q26800114 | Advanced glycation end-products: modifiable environmental factors profoundly mediate insulin resistance |
| Q43270496 | Aggregates of denatured proteins stimulate nitric oxide and superoxide production in macrophages |
| Q40477757 | Characterisation of the advanced glycation endproduct receptor complex in the retinal pigment epithelium |
| Q33609776 | Controlling the receptor for advanced glycation end-products to conquer diabetic vascular complications |
| Q34287672 | Covalent binding antibodies suppress advanced glycation: on the innate tier of adaptive immunity. |
| Q39257820 | Effects of crystallin-β-b2 on stressed RPE in vitro and in vivo |
| Q90152813 | Galectin-3 Is a Potential Mediator for Atherosclerosis |
| Q28069174 | Galectin-3 and IL-33/ST2 axis roles and interplay in diet-induced steatohepatitis |
| Q55383284 | Galectin-3 and incident cognitive impairment in REGARDS, a cohort of blacks and whites. |
| Q38362263 | Galectin-3 binds lactosaminylated lipooligosaccharides from Neisseria gonorrhoeae and is selectively expressed by mucosal epithelial cells that are infected |
| Q40944709 | Galectin-3 deficiency accelerates high-fat diet-induced obesity and amplifies inflammation in adipose tissue and pancreatic islets |
| Q35842591 | Galectin-3 deficiency exacerbates hyperglycemia and the endothelial response to diabetes |
| Q44466555 | Galectin-3 expression in macrophages is signaled by Ras/MAP kinase pathway and up-regulated by modified lipoproteins |
| Q36357458 | Galectin-3 gene inactivation reduces atherosclerotic lesions and adventitial inflammation in ApoE-deficient mice |
| Q41134548 | Hepatic expression of galectin-3 and receptor for advanced glycation end products in patients with liver disease |
| Q42767408 | Inhibition of advanced glycation and absence of galectin-3 prevent blood-retinal barrier dysfunction during short-term diabetes. |
| Q26795694 | Linking RAGE and Nox in diabetic micro- and macrovascular complications |
| Q34309578 | Low serum galectin-3 concentrations are associated with insulin resistance in patients with type 2 diabetes mellitus |
| Q35828555 | Mechano-transduction mediated secretion and uptake of galectin-3 in breast carcinoma cells: implications in the extracellular functions of the lectin |
| Q39407960 | Novel role for galectin-8 protein as mediator of coagulation factor V endocytosis by megakaryocytes |
| Q35494903 | Regulation of RAGE for attenuating progression of diabetic vascular complications |
| Q38154222 | The emerging role of Galectin-3 and ST2 in heart failure: practical considerations and pitfalls using novel biomarkers |
| Q77530330 | The liver is the main site for metabolism of circulating advanced glycation end products |
| Q63241252 | The physiological scavenger receptor function of hepatic sinusoidal endothelial and Kupffer cells is independent of scavenger receptor class A type I and II |
| Q34348813 | The role of AGEs in aging: causation or correlation |
Search more.